Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2006

Conditions
ADHD
Interventions
DRUG

Modafinil

Trial Locations (39)

22180

Advanced Pediatrics, Vienna

23112

Dominion Clinical Research, Midlothian

29425

Medical University of SC, Charleston

30060

Northwest Behavioral Research, Marietta

30189

Pediatrics and Adolescent, Woodstock

32216

Clinical Neuroscience Solution, Jacksonville

32607

Sarkis Clinical Trials, Gainesville

32806

Clinical Neurosciences, Orlando

33407

Laszlo J. Mate, MD, PA, West Palm Beach

38105

UT Medical Group, Memphis

38119

Clinical Neuroscience Solution, Memphis

40509

Michael J. Rieser, MD, Lexington

42301

Pedia Research, LLC, Owensboro

45229

Cincinnati Children's Hospital, Cincinnati

48126

Odyssey Research, Dearborn

48503

Hurley Medical Center, Flint

49008

ProMed HealthCare, Kalamazoo

55101

Regions Hospital, Saint Paul

58104

Prairie at Saint John's, Fargo

58501

Odyssey Research, Bismarck

58701

Odyssey Research, Minot

60062

HALP Clinic and ADHD Research, Northbrook

60153

Loyola University Medical Center Department of Psychiatry, Maywood

67207

Cientifica, Inc., Wichita

69001

Odyssey Research, McCook

70114

Louisiana Research Associates, New Orleans

71103

Psycopharmacology Research - LSU Health Science Center, Shreveport

77401

Claghorn-Lesem Research, Bellaire

85254

Melmed Center, Scottsdale

91324

Pharmacology Research Institut, Northridge

92121

Pacific Sleep Medicine Service, San Diego

92612

UCI Child Development Center, Irvine

97301

OCCI, Inc Salem, Salem

98033

Eastside Therapeutic Resource, Kirkland

02138

Massachusetts General Hospital, Cambridge

68198-7630

University of Nebraska, Omaha

08034

Bancroft Clinical Research, Cherry Hill

08822

Hunterdon Pediatric Associates, Flemington

05401

The Clinical Study Ceneter, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00228540 - Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD | Biotech Hunter | Biotech Hunter